What Happened
INTEGRIS ProHealth, Inc. and its parent, INTEGRIS Health, Inc., paid $120,000 in July 2022 to settle civil penalty claims in Oklahoma City. The United States alleged that Integris Baptist Medical Center Pharmacy failed in October 2021 to notify the DEA within one business day of discovering thefts of fentanyl and hydromorphone, Schedule II controlled substances, by a former employee. The settlement resolved claims under the Comprehensive Drug Abuse Prevention and Control Act of 1970. INTEGRIS did not admit liability, and the DEA Office of Diversion Control investigated.
“failed to report within one business day of discovery the thefts of fentanyl and hydromorphone by a former employee”
Related Guidance
- 15 Red Flags of Drug Diversion — Behavioral and transactional indicators of diversion.
- Investigation Playbook — How to investigate suspected diversion inside an organization.